Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Conditions

• Solid Tumor
• Extensive-stage Small-cell Lung Cancer
• Locally Advanced Breast Cancer
• Metastatic Breast Cancer
• Platinum-sensitive Ovarian Cancer
• Platinum-Sensitive Fallopian Tube Carcinoma
• Platinum-Sensitive Peritoneal Cancer

Interventions

• DRUG: RP12146

Sponsor

Rhizen Pharmaceuticals SA